scholarly journals A case study for the use of medical cannabis in generalized anxiety disorder

Discoveries ◽  
2019 ◽  
Vol 7 (2) ◽  
pp. e92
Author(s):  
Chad Walkaden ◽  
2018 ◽  
Vol 9 (2) ◽  
pp. S22
Author(s):  
C. Chandni Pillai ◽  
C. Mahesh Kundagol ◽  
James Chacko ◽  
Devipriya Soman

2014 ◽  
Vol 75 (11) ◽  
pp. e17-e18 ◽  
Author(s):  
Pedro Shiozawa ◽  
Andre Pereira G. Leiva ◽  
Claudia Dornfeld C. Castro ◽  
Mailu Enokibara da Silva ◽  
Quirino Cordeiro ◽  
...  

2015 ◽  
Vol 8 (3) ◽  
pp. 659-660 ◽  
Author(s):  
Alisson Paulino Trevizol ◽  
Pedro Shiozawa ◽  
Isa Albuquerque Sato ◽  
Elie Leal de Barros Calfat ◽  
Rodrigo Lancelote Alberto ◽  
...  

2017 ◽  
Vol 4 (2) ◽  
Author(s):  
Shilpi Aggarwal ◽  
Prashant Srivastava

Objectives: The present study aims to explore the course of generalized anxiety disorder and to assess the application of psycho-social management in alleviating the symptoms associated with generalized anxiety disorder and to improve the client’s overall functioning. Research design: Case study. Sample and method: This study was carried out in Hyderabad and 33 years old married male was included. Treatment plan was formulated according to psycho-social management wherein different management techniques were utilised to modify the client’s generalized anxiety beliefs and the associated behaviours. Result: Findings of the assessment showed significant distress and impairment in overall functioning. Stressor activates his dysfunctional belief which shifts his attention to minor perceptual disturbance and results in misinterpretation of these trivial variations. Psycho-social management techniques successfully restructured his dysfunctional beliefs and remarkably improved his functioning. Conclusion: On the basis of results, it can be ascertained that psycho-social management is an effective approach to treat generalized anxiety disorder.


2018 ◽  
Vol 7 (1) ◽  
pp. 1-13 ◽  
Author(s):  
Lisa A. Benson ◽  
Brian D. Doss ◽  
Andrew Christensen

This article describes recent developments in online interventions for distressed couples, with a focus on an adaptation of an online program to address the needs of couples in which one partner has Generalized Anxiety Disorder (GAD). This program, OurRelationship.com, is based on Integrative Behavioral Couple Therapy, an empirically supported treatment which builds closeness between partners through empathy and acceptance of one another’s differences rather than emphasizing short-term change. We review the rationale for adapting the OurRelationship.com program to focus on couples affected by GAD, the structure of this intervention, and a brief case study illustrating our clinical approach. In this case study, a couple who participated in the online intervention reported that by the end of the program, they had been able to recognize the patterns of communication they had developed related to the female partner’s generalized anxiety. Moreover, they reported they had been able to develop new strategies for responding to these issues that improved the quality of their relationship.


2021 ◽  
pp. 070674372110433
Author(s):  
Cerina Lee ◽  
Jessica M. Round ◽  
John G. Hanlon ◽  
Elaine Hyshka ◽  
Jason R.B. Dyck ◽  
...  

Objectives Despite increasing rates of legalization of medical cannabis worldwide, the current evidence available on its effect on mental health outcomes including anxiety is of mixed results. This study assesses the effect of medical cannabis on generalized anxiety disorder 7-item (GAD-7) scores in adult patients between 2014 and 2019 in Ontario and Alberta, Canada. Methods An observational cohort study of adults authorized to use medical cannabis. The GAD-7 was administered at the time of the first visit to the clinic and subsequently over the follow-up time period of up to 3.2 years. Overall changes in GAD-7 scores were computed (mean change) and categorized as: no change (<1 point); improvement; or worsening—over time. Results A total of 37,303 patients had initial GAD-7 scores recorded and 5,075 (13.6%) patients had subsequent GAD-7 follow-up scores. The average age was 54.2 years (SD 15.7 years), 46.0% were male, and 45.6% noted anxiety symptoms at the baseline. Average GAD-7 scores were 9.11 (SD 6.6) at the baseline and after an average of 282 days of follow-up (SD 264) the average final GAD-7 score recorded was 9.04 (SD 6.6): mean change −0.23 (95% CI, −0.28 to −0.17, t[5,074]: −8.19, p-value <0.001). A total of 4,607 patients (90.8%) had no change in GAD-7 score from their initial to final follow-up, 188 (3.7%) had a clinically significant decrease, and 64 (1.3%) noted a clinically significant increase in their GAD-7 scores. Conclusions Overall, there was a statistically significant decrease in GAD-7 scores over time (in particular, in the 6–12-month period). However, this change did not meet the threshold to be considered clinically significant. Thus, we did not detect clinical improvements or detriment in GAD-7 scores in medically authorized cannabis patients. However, future well-controlled clinical trials are needed to fully examine risks or benefits associated with using medical cannabis to treat anxiety conditions.


Sign in / Sign up

Export Citation Format

Share Document